Jim Fee joined our board as a representative of the Oregon Angel Fund.  Mr. Fee has spent 40 years in the medical device industry having most recently served as Vice-President and General Manager Welch Allyn Defibrillation and, President of Medical Research Laboratories, a Welch Allyn Company. Mr. Fee spent 12 years at Protocol Systems as VP Global Sales and Marketing from start-up through public offering and acquisition by Welch Allyn. For 6 years he held VP of Sales and Marketing positions at Physio-Control. Mr. Fee served on the board of directors of privately held Acrymed, Inc. from 1996 until it was acquired in 2008. He is currently Executive Director of the Achon Uganda Children’s Fund, a not-for-profit organization supporting orphans and providing healthcare in Northern Uganda. His B.S. in Biology and M.S in Physiology are from Marquette University.  Jim is based in Portland, Oregon.

Mr. Fee replaces Tim Lynch, who represented the original BVC investor group.  The company thanks Mr. Lynch for his service, and is pleased he has agreed to stay on as an advisor in the coming years.